165 related articles for article (PubMed ID: 10442363)
1. Using preoperative UFT to predict sensitivity to fluoropyrimidines in colorectal cancer.
Fujii M
Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):55-60. PubMed ID: 10442363
[TBL] [Abstract][Full Text] [Related]
2. An anticancer drug sensitivity test to determine the effectiveness of UFT as postoperative adjuvant chemotherapy for patients with stage III colorectal cancer.
Isogai A; Nagaya M; Matsuoka H; Watanabe T; Tsukikawa S; Kubota S
Surgery; 2007 Nov; 142(5):741-8. PubMed ID: 17981195
[TBL] [Abstract][Full Text] [Related]
3. Clinical identification of colorectal cancer patients benefiting from adjuvant uracil-tegafur (UFT): a randomized controlled trial.
Fujii M; Takayama T; Kochi M
J Cancer Res Clin Oncol; 2008 Dec; 134(12):1319-23. PubMed ID: 18512074
[TBL] [Abstract][Full Text] [Related]
4. Multicenter randomized prospective study of adjuvant chemotherapy with UFT and mitomycin C in advanced colorectal cancer.
Nakagoe T; Ishikawa H; Sawai T; Tuji T; Ayabe H; Eida K; Nogawa T; Nakamura Y; Kunisaki T; Tobinaga K; Furukawa M; Ino M
Anticancer Res; 2000; 20(2B):1069-75. PubMed ID: 10810399
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant Oral Uracil-Tegafur with Leucovorin for Colorectal Cancer Liver Metastases: A Randomized Controlled Trial.
Hasegawa K; Saiura A; Takayama T; Miyagawa S; Yamamoto J; Ijichi M; Teruya M; Yoshimi F; Kawasaki S; Koyama H; Oba M; Takahashi M; Mizunuma N; Matsuyama Y; Watanabe T; Makuuchi M; Kokudo N
PLoS One; 2016; 11(9):e0162400. PubMed ID: 27588959
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of oral tegafur-uracil as maintenance therapy following intravenous 5-fluorouracil chemotherapy in stage III colon cancer.
Hong KD; Lee SI; Moon HY
Hepatogastroenterology; 2012; 59(113):104-7. PubMed ID: 22251527
[TBL] [Abstract][Full Text] [Related]
7. Sequential paclitaxel followed by tegafur and uracil (UFT) or S-1 versus UFT or S-1 monotherapy as adjuvant chemotherapy for T4a/b gastric cancer (SAMIT): a phase 3 factorial randomised controlled trial.
Tsuburaya A; Yoshida K; Kobayashi M; Yoshino S; Takahashi M; Takiguchi N; Tanabe K; Takahashi N; Imamura H; Tatsumoto N; Hara A; Nishikawa K; Fukushima R; Nozaki I; Kojima H; Miyashita Y; Oba K; Buyse M; Morita S; Sakamoto J
Lancet Oncol; 2014 Jul; 15(8):886-93. PubMed ID: 24954805
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of oral UFT as adjuvant chemotherapy to curative resection of colorectal cancer: multicenter prospective randomized trial.
Kato T; Ohashi Y; Nakazato H; Koike A; Saji S; Suzuki H; Takagi H; Nimura Y; Hasumi A; Baba S; Manabe T; Maruta M; Miura K; Yamaguchi A
Langenbecks Arch Surg; 2002 Mar; 386(8):575-81. PubMed ID: 11914933
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of preoperative chemotherapy for colorectal cancer].
Nishimura G; Michiwa Y; Yagi H; Sato T; Fushida S; Fugimura T; Sugiyama K; Kanno M; Yonemura Y; Miwa K; Miyazaki I; Yamaguchi A
Gan To Kagaku Ryoho; 1996 Jan; 23(1):69-74. PubMed ID: 8546472
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of the preoperative administration of tegafur suppositories as alternative adjuvant chemotherapy for patients with resectable stage II or III colorectal cancer: a KODK4 multicenter randomized control trial.
Okabayashi K; Hasegawa H; Watanabe M; Ohishi T; Hisa A; Kitagawa Y
Oncology; 2012; 83(1):16-23. PubMed ID: 22722481
[TBL] [Abstract][Full Text] [Related]
11. Enhanced induction of apoptosis in lung adenocarcinoma after preoperative chemotherapy with tegafur and uracil (UFT).
Morio A; Miyamoto H; Izumi H; Futagawa T; Oh T; Yamazaki A; Konno H
Surg Today; 2004; 34(10):822-7. PubMed ID: 15449150
[TBL] [Abstract][Full Text] [Related]
12. Postsurgical sequential methotrexate/5-FU and leucovorin on outpatient basis for advanced colorectal carcinoma.
Tokunaga Y; Kitaoka A; Yagi T; Tokuka A; Ohsumi K
Hepatogastroenterology; 2001; 48(37):128-32. PubMed ID: 11268947
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of postoperative UFT (Tegafur/Uracil) plus PSK therapies in elderly patients with resected colorectal cancer.
Yoshitani S; Takashima S
Cancer Biother Radiopharm; 2009 Feb; 24(1):35-40. PubMed ID: 19243246
[TBL] [Abstract][Full Text] [Related]
14. [Subset analysis of preoperative lymphocyte ratio in stage II or III colorectal cancer patients treated with oral tegafur-uracil and protein-bound polysaccharide K].
Totsuka O; Kawate S; Hirai K; Ogawa H; Toya H; Yoshinari D; Sunose Y; Takeyoshi I
Gan To Kagaku Ryoho; 2013 Dec; 40(13):2525-8. PubMed ID: 24335363
[TBL] [Abstract][Full Text] [Related]
15. Metronomic chemotherapy with tegafur-uracil following radical resection in stage II colorectal cancer.
Chen TC; Jeng YM; Liang JT
J Formos Med Assoc; 2021 May; 120(5):1194-1201. PubMed ID: 33023787
[TBL] [Abstract][Full Text] [Related]
16. Uracil-tegafur as an adjuvant for hepatocellular carcinoma: a randomized trial.
Hasegawa K; Takayama T; Ijichi M; Matsuyama Y; Imamura H; Sano K; Sugawara Y; Kokudo N; Makuuchi M
Hepatology; 2006 Oct; 44(4):891-5. PubMed ID: 17006925
[TBL] [Abstract][Full Text] [Related]
17. [The feasibility of oral fluoropyrimidines as adjuvant chemotherapy after resection and local coagulation therapy of colorectal liver metastases].
Narita T; Seshimo A; Itabashi M; Aratake K; Ogawa S; Hirosawa T; Hashimoto T; Amano K; Kameoka S
Gan To Kagaku Ryoho; 2011 Nov; 38(11):1821-4. PubMed ID: 22083190
[TBL] [Abstract][Full Text] [Related]
18. Long-term results of a phase II trial of high-dose radiotherapy (60 Gy) and UFT/l-leucovorin in patients with non-resectable locally advanced rectal cancer (LARC).
Vestermark LW; Jacobsen A; Qvortrup C; Hansen F; Bisgaard C; Baatrup G; Rasmussen P; Pfeiffer P
Acta Oncol; 2008; 47(3):428-33. PubMed ID: 18348002
[TBL] [Abstract][Full Text] [Related]
19. [Multihospital randomized study on pre- and post-operative adjuvant chemotherapy for colorectal cancer (Part 2)].
Ishikawa H; Tomita M; Shimoyama T; Hirano T; Nakagoe T; Shimizu T; Kusano H; Eida K; Ishii T; Kotake Y
Gan To Kagaku Ryoho; 1991 Feb; 18(2):277-82. PubMed ID: 1899550
[TBL] [Abstract][Full Text] [Related]
20. The MMP-9 expression determined the efficacy of postoperative adjuvant chemotherapy using oral fluoropyrimidines in stage II or III colorectal cancer.
Ogata Y; Matono K; Sasatomi T; Ishibashi N; Ohkita A; Mizobe T; Ogo S; Ikeda S; Ozasa H; Shirouzu K
Cancer Chemother Pharmacol; 2006 May; 57(5):577-83. PubMed ID: 16133529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
